Financial and Operating Highlights1, 2
• Diluted EPS of $0.51, down from $0.61
• Net revenue of $602 million, down 9%, including $22 million negative FX impact
• Fixed operating expenses of $396 million, down 5% on a constant dollar / portfolio basis
• Operating income of $206 million, down 15%, including $11 million negative FX impact
• EBITDA margin of 45% vs. 47%; Debt to EBITDA ratio 2.1times
• Repurchased 6.9 million shares at average price of $25.60; 11.2 million shares year-to-date
• Board declares third quarter 2012 cash dividend of $0.30 per share
1 All comparisons versus 2Q11 unless otherwise stated. Excludes merger expenses, exit costs, disposal activities and discrete tax items.
2 A full reconciliation of our non-GAAP results to our GAAP results is included in the attached tables. See also our statement on non-GAAP financial measures at the end of this earnings release.
NYSE Euronext (NYX) today reported net income of $125 million, or $0.49 per diluted share, for the second quarter of 2012, compared to net income of $154 million, or $0.59 per diluted share, for the second quarter of 2011. Results for the second quarter of 2012 and 2011 include $12 million and $18 million, respectively, of pre-tax merger expenses and exit costs. Second quarter 2012 results also include a net $2 million loss from disposal activities related to the previously announced wind down of NYSE Blue. Excluding merger expenses, exit costs, disposal activities and discrete tax items, net income in the second quarter of 2012 was $128 million, or $0.51 per diluted share, compared to $160 million, or $0.61 per diluted share, in the second quarter of 2011.
“We made good progress in executing against our strategy to unlock the inherent value of our community,” said Duncan L. Niederauer, CEO, NYSE Euronext. “We have realigned our client facing and product teams to create a generalist sales force that brings to bear our full-suite of solutions for our clients. We have given notice that we will fully insource clearing and launch NYSE Clearing in June 2013, which will provide us with cost savings and ultimately provide new revenue and better position the Company for the OTC opportunity. Lastly, we made significant headway with our NYSE Liffe U.S. platform with the launch of our GCF repo futures product which fills the increasing market need for a reliable and transparent benchmark for bank funding costs.”
The table below summarizes the financial results1 for the second quarter of 2012:
% Δ 2Q12 | Year-to-Date | % Δ YTD '12 | |||||||||||||||
($ in millions, except EPS) | 2Q12 | 1Q12 | 2Q11 | vs. 2Q11 | 2012 | 2011 | vs. YTD '11 | ||||||||||
Total Revenues 2 | $986 | $952 | $1,092 | (10%) | $1,938 | $2,240 | (13%) | ||||||||||
Total Revenues, Less Transaction-Based Expenses3 | 602 | 601 | 661 | (9%) | 1,203 | 1,340 | (10%) | ||||||||||
Other Operating Expenses 4 | 396 | 405 | 419 | (5%) | 801 | 834 | (4%) | ||||||||||
Operating Income 4 | $206 | $196 | $242 | (15%) | $402 | $506 | (21%) | ||||||||||
Net Income 4 | $128 | $121 | $160 | (20%) | $249 | $337 | (26%) | ||||||||||
Diluted Earnings Per Share 4 | $0.51 | $0.47 | $0.61 | (16%) | $0.97 | $1.28 | (24%) | ||||||||||
Operating Margin | 34% | 33% | 37% | (3 ppts) | 33% | 38% | (5 ppts) | ||||||||||
Adjusted EBITDA Margin | 45% | 44% | 47% | (2 ppts) | 44% | 48% | (4 ppts) |
1 A full reconciliation of our non-GAAP results to our GAAP results is included in the attached tables. See also our statement on non-GAAP financial measures at the end of this earnings release.
2 Includes activity assessment fees.
3 Transaction-based expenses include Section 31 fees, liquidity payments and routing & clearing fees.
4 Excludes merger expenses, exit costs, disposal activities and discrete tax items.
“We are making excellent progress on the efficiency and capital deployment streams of Project 14,” commented Michael S. Geltzeiler, Group Executive Vice President and CFO, NYSE Euronext. “Year-to-date, excluding investments and foreign exchange fluctuations, we have reduced operating costs by $35 million, or 4% which puts us on track to exceed our year-one cost savings commitments. On the capital front, we spent $304 million of the $552 million share repurchase authorization, purchasing 11 million shares year-to-date. Ongoing strategic initiatives, combined with our cost reduction plan and lower share count from stock repurchases, should position the Company for a return to earnings growth in 2013 and beyond.”
SECOND QUARTER 2012 CONSOLIDATED RESULTS
Total revenues, less transaction-based expenses, which include Section 31 fees, liquidity payments and routing and clearing fees (net revenue), were $602 million in the second quarter of 2012, down $59 million, or 9% compared to the second quarter of 2011 and included a $22 million negative impact from foreign currency fluctuations. The $37 million decrease in net revenue, on a constant currency basis, compared to the second quarter of 2011 was primarily driven by lower average daily volumes (“ADV”), mostly attributable to the derivatives business.
Other operating expenses, excluding merger expenses and exit costs, were $396 million in the second quarter of 2012, down $23 million, or 5% compared to the second quarter of 2011. Excluding the impact of new business initiatives and an $11 million positive impact attributable to foreign currency fluctuations, other operating expenses were also down $23 million, or 5%, compared to the second quarter of 2011.
Operating income, excluding merger expenses and exit costs, was $206 million, down $36 million, or 15% compared to the second quarter of 2011 and included an $11 million negative impact attributable to foreign currency fluctuations.
Adjusted EBITDA, excluding merger expenses and exit costs was $272 million, down $40 million, or 13% compared to the second quarter of 2011. Adjusted EBITDA margin was 45% in the second quarter of 2012, compared to 47% in the second quarter of 2011.
Non-operating results for the second quarter of 2012 and 2011 includes the impact of New York Portfolio Clearing (loss from associates), NYSE Liffe U.S. (net loss attributable to non-controlling interest) and NYSE Amex Options (net profit attributable to non-controlling interest). The loss attributable to the non-controlling interest related to NYSE Liffe U.S. was $2 million in the second quarter of 2012, based on the partners’ 42% stake in the business. At the end of the second quarter of 2012, NYSE Liffe U.S. sold a 7% equity stake in the business to the existing partner group, raising the partner groups’ collective stake in the business to 49%. The profit attributable to the non-controlling interest related to NYSE Amex Options was $8 million in the second quarter of 2012, based on the partners’ 47.8% stake in the business.
The effective tax rate for the second quarter of 2012, excluding merger expenses, exit costs and discrete tax items, was approximately 25% compared to approximately 26% for the second quarter of 2011.
The weighted average diluted shares outstanding in the second quarter of 2012 was 253 million, down from 263 million in second quarter of 2011. During the second quarter of 2012, a total of 6.9 million shares were repurchased at an average price of $25.60 per share. The current $552 million stock repurchase authorization has $248 million remaining as of June 30, 2012.
At June 30, 2012, total debt was $2.3 billion. Cash, cash equivalents and short term financial investments (including $153 million related to Section 31 fees collected from market participants and due to the SEC) were $0.4 billion and net debt was $1.9 billion at the end of the second quarter of 2012. The ratio of debt-to-EBITDA at the end of the second quarter of 2012 was 2.1X.
NYSE Euronext entered into a $1 billion senior unsecured credit facility agreement with a three-year maturity. The financing replaces NYSE Euronext’s existing $1.2 billion credit facility, which was entered into in 2007 and was scheduled to mature on July 31, 2012. The new revolving bank facility is available for general corporate purposes and will mature on June 15, 2015.
Total capital expenditures were $41 million in the second quarter of 2012 and $84 million year-to-date. This is in-line with our full-year 2012 capital expenditures guidance.
Headcount as of June 30, 2012 of 3,062 was 17 below first quarter 2012 levels despite the addition of 99 employees from the acquisition of Corpedia in June of 2012. The reduction was due to the wind down of NYSE Blue (66 headcount) and the ongoing staff rationalization program.
The Board of Directors declared a cash dividend of $0.30 per share for the third quarter of 2012. The third quarter 2012 dividend is payable on September 28, 2012 to shareholders of record as of the close of business on September 14, 2012. The anticipated ex-date will be September 12, 2012.
SECOND QUARTER 2012 SEGMENT RESULTS
Below is a summary of business segment results:
Derivatives | Cash Trading & Listings | Info. Svcs. & Tech. Solutions | |||||||||||||
($ in millions) | Net | Operating | Adjusted | Net | Operating | Adjusted | Operating | Adjusted | |||||||
Revenue1 | Income2 | EBITDA2 | Revenue1 | Income2 | EBITDA2 | Revenue | Income2 | EBITDA2 | |||||||
2Q12 | $182 | $85 | $95 | $300 | $127 | $170 | $119 | $27 | $40 | ||||||
1Q12 | $176 | $79 | $89 | $304 | $119 | $161 | $121 | $28 | $42 | ||||||
2Q11 | $213 | $112 | $126 | $327 | $128 | $174 | $122 | $36 | $46 | ||||||
YTD 2012 | $358 | $164 | $184 | $604 | $246 | $331 | $240 | $55 | $82 | ||||||
YTD 2011 | $449 | $258 | $287 | $655 | $253 | $345 | $238 | $64 | $83 |
1 Net revenue defined as total revenues less transaction-based expenses including Section 31 fees, liquidity payments and routing & clearing fees.
2 Excludes merger expenses and exit costs.
DERIVATIVES
Derivatives net revenue of $182 million in the second quarter of 2012 decreased $31 million, or 15% compared to the second quarter of 2011 and included a $6 million negative impact from foreign currency fluctuations. The $25 million decrease in derivatives net revenue, on a constant currency basis, compared to the second quarter of 2011, was driven by lower trading volumes.
• Global derivatives ADV in the second quarter of 2012 of 8.6 million contracts decreased 8% compared to the second quarter of 2011, but increased 14% compared to first quarter of 2012 levels.
• NYSE Euronext European derivatives products ADV of 4.7 million contracts in the second quarter of 2012 decreased 12% compared to the second quarter of 2011, but increased 40% from first quarter of 2012 levels. Excluding Bclear, European derivatives products ADV in the second quarter of 2012 decreased 8% compared to the second quarter of 2011, but increased 9% from the first quarter of 2012.
• On June 29, 2012, NYSE Euronext gave formal notice of termination with respect to the services currently received from LCH.Clearnet Ltd under the Clearing Relationship Agreement to support NYSE Liffe Clearing, NYX’s London-based derivatives clearing service. Subject to regulatory approval, NYSE Liffe intends to expand NYSE Liffe Clearing to commence functioning as a fully integrated Central Counterparty, NYSE Clearing, from the end of June 2013. NYSE Clearing will assume responsibility for default management arrangements, risk management, collateral and treasury activities as well as banking and payment systems.
• U.S. equity options ADV in the second quarter of 2012 decreased 3% to 3.9 million contracts compared to the second quarter of 2011 and decreased 5% from the first quarter of 2012. U.S. consolidated equity options ADV of 14.9 million contracts decreased 5% compared to the second quarter of 2011 and decreased 6% from the first quarter of 2012. NYSE Euronext’s U.S. equity options exchanges accounted for 26.3% of total consolidated U.S. equity options trading in the second quarter of 2012, up from 25.7% in the second quarter of 2011 and up from 26.0% in the first quarter of 2012. NYSE Amex Options had record quarterly market share in the second quarter of 2012 of 15.7%.
• NYSE Liffe U.S. ADV in the second quarter of 2012 was approximately 73,400 contracts compared to 93,400 contracts in the second quarter of 2011 and 96,300 contracts in the first quarter of 2012. At the end of the second quarter 2012, NYSE Liffe U.S. celebrated the one-year anniversary as the sole U.S. futures exchange trading contracts based on MSCI indices. The indices have registered strong growth in volume and open interest over the past year, particularly in the contracts based on the benchmark MSCI Emerging Markets and MSCI EAFE indices. Nearly 190,000 lots of mini MSCI Index futures open interest are currently established on NYSE Liffe U.S., representing a notional value of over $10 billion. Open interest in the mini MSCI Emerging Markets contracts and mini MSCI EAFE contracts have increased 204% to 117,529 and 108% to 67,828, respectively since the migration from the CME in June 2011.
• NYSE Liffe U.S. continued to expand the product breadth of the platform with the launch of futures on the DTCC GCF Repo Index. Additionally, in June 2012 NYSE Liffe U.S. sold a 7% equity stake in the business to the existing partner group, raising the partner groups’ collective stake in the business to 49%.
CASH TRADING AND LISTINGS
Cash Trading and Listings net revenue of $300 million in the second quarter of 2012 decreased $27 million, or 8% compared to the second quarter of 2011 and included an $11 million negative impact from foreign currency fluctuations. The $16 million decrease in net revenue, on a constant currency basis, compared to the second quarter of 2011 was primarily driven by lower average net revenue capture for European cash trading.
• European cash ADV of 1.7 million transactions in the second quarter of 2012 increased 11% from 1.5 million transactions in the second quarter of 2011 and increased 8% from first quarter of 2012 levels. European cash market share (value traded) in NYSE Euronext’s four core markets was 66% in the second quarter of 2012, down from 71% in the second quarter of 2011, but up from 65% in the first quarter of 2012.
• In the U.S., cash trading ADV in the second quarter of 2012 decreased 12% to 1.8 billion shares traded from 2.1 billion in the second quarter of 2011, but increased 2% from the first quarter of 2012. Tape A matched market share was 32% in the second quarter of 2012, down from 35% in the second quarter of 2011, but up from 31% in the first quarter of 2012.
• NYSE Euronext received approval from the U.S. Securities and Exchange Commission to establish a first-of-its-kind Retail Liquidity Program (“RLP”), a market innovation that produces cost savings for individual investors through price improvement on retail equities trading order flow for New York Stock Exchange (NYSE) and NYSE MKT listed and NASDAQ UTP-traded equity securities. The RLP is complementary to existing marketplace offerings for retail investors and is intended for use by retail brokerage firms directly and market intermediaries that service retail order flow providers.
• In the first half of 2012, NYSE Euronext raised $17.1 billion in total global proceeds on 66 Initial Public Offerings (IPOs). In the U.S., NYSE Euronext listed 62% of all IPOs, bringing 56 IPOs to the U.S. market. NYSE Euronext has steadily captured share in technology-based IPOs. In the first half of 2012, NYSE Euronext listed 52% of the technology IPOs in the U.S., including the recent IPO of ServiceNow, Inc. Technology-based listings on NYSE in the first half of 2012 included Demandware Inc., Exact Target Inc., Guidewire Software Inc., Infoblox Inc., Millennial Media Inc. and Yelp Inc. For the second half of 2012, the pipeline of technology deals is strong.
• In the first half of 2012, eight companies transferred to the NYSE with three departures from the NYSE and one from NYSE MKT. Of the eight companies that moved to the NYSE in 2012, two were among the top 100 market capitalization companies listed on NASDAQ - Teva Pharmaceutical Industries Ltd., which was part of the NASDAQ 100 Index and TD Ameritrade Holding Corporation. Since 2010, a total of 38 companies have transferred to NYSE and 14 have transferred to another U.S. exchange giving NYSE Euronext a win rate of approximately 3:1.
• In Europe, Groupe Eurotunnel was the first company to be admitted to NYSE Euronext London and began trading on July 19, 2012. BTG Pactual, Brazil's largest investment bank, listed on NYSE Alternext Amsterdam and Solvay, a leading global player in chemicals completed a secondary listing on NYSE Euronext in Paris. In the U.S., global industry leaders such as AVG Technologies NV from Czech Republic, Cementos Pacasmayo from Peru and Cencosud S.A. from Chile, all listed on NYSE.
• NYSE Euronext acquired Corpedia Corporation, a leading global provider of ethics and compliance e-learning and consultative services. With its corporate governance, risk and compliance (GRC) assets, Corpedia will further expand NYSE Euronext’s extensive range of global services available to companies. The transaction closed in June 2012.
INFORMATION SERVICES AND TECHNOLOGY SOLUTIONS
Information Services and Technology Solutions revenue was $119 million in the second quarter of 2012, a decrease of $3 million, or 2% compared to the second quarter of 2011 and included a $5 million negative impact from foreign currency fluctuations. The $2 million increase in revenue, on a constant currency basis, compared to the second quarter of 2011, was driven by higher connectivity revenue. The slower growth in revenue year-over-year is the result of the challenging environment for financial services technology sales which has delayed client decisions on purchases of software and connectivity services.
• NYSE Technologies announced a market data partnership with the Warsaw Stock Exchange (WSE). Customers will now have access to the WSE’s market data services via NYSE Technologies’ innovative suite of market data products and services. NYSE Euronext and the WSE continue their strategic collaboration (initially formed in 2010) working on a series of projects including the ongoing implementation of the NYSE Technologies Universal Trading Platform and the continuing development of a range of technology cooperation for the WSE.
• NYSE Technologies announced the global expansion of its successful Capital Markets Community Platform into Europe. Operating from NYSE Euronext’s European liquidity center in Basildon, the cloud based Community Platform was designed and developed in partnership with leading computing experts EMC and VMware. NYSE Technologies’ Capital Markets Community Platform was designed to increase business agility, simplify market access and reduce trading friction by utilizing rapid on-demand computing resources. Originally launched on July 1, 2011 from NYSE Euronext’s U.S. liquidity center in Mahwah, this is the first cloud based capital markets community platform developed exclusively for the financial services industry.
• NYSE Euronext announced that its U.S. liquidity center in Mahwah, New Jersey has enhanced its data center community, managed by NYSE Technologies, by revising a number of policies aimed at reducing customer costs, increasing platform flexibility and broadening access to the facility. For the first time, the financial services vendor community has the opportunity to acquire data center space and offer their services within NYSE Technologies’ state-of-the-art liquidity center.
• NYSE Technologies and Xignite Inc., a provider of web-based market data services, announced their agreement to launch a new service providing access to real-time, historical and reference market data for all NYSE Euronext markets via the Internet.
# # #
The accompanying tables include information integral to assessing the Company’s financial performance.
Analyst/Investor/Media Call: August 3, 2012 at 8:00 a.m. (NY/ET) / 2:00 p.m. (Paris/CEST)
A presentation and live audio webcast of the Second quarter 2012 earnings conference call will be available on the Investor Relations section of NYSE Euronext’s website, http://www.nyseeuronext.com/ir. Those wishing to listen to the live conference via telephone should dial-in at least ten minutes before the call begins. An audio replay of the conference call will be available approximately one hour after the call on the Investor Relations section of NYSE Euronext’s website, http://www.nyseeuronext.com/ir or by dial-in beginning approximately two hours following the conclusion of the live call.
Live Dial-in Information:
United States: 800.901.5241
International: 617.786.2963
Passcode: 71048755
Replay Dial-in Information:
United States: 888.286.8010
International: 617.801.6888
Passcode: 97290929
Non-GAAP Financial Measures
To supplement NYSE Euronext’s consolidated financial statements prepared in accordance with GAAP and to better reflect period-over-period comparisons, NYSE Euronext uses non-GAAP financial measures of performance, financial position, or cash flows that either exclude or include amounts that are not normally excluded or included in the most directly comparable measure, calculated and presented in accordance with GAAP. Non-GAAP financial measures do not replace and are not superior to the presentation of GAAP financial results, but are provided to (i) present the effects of certain merger expenses, exit costs, the BlueNext tax settlement, disposal activities and discrete tax items, and (ii) improve overall understanding of NYSE Euronext’s current financial performance and its prospects for the future. Specifically, NYSE Euronext believes the non-GAAP financial results provide useful information to both management and investors regarding certain additional financial and business trends relating to financial condition and operating results. In addition, management uses these measures for reviewing financial results and evaluating financial performance. The non-GAAP adjustments for all periods presented are based upon information and assumptions available as of the date of this release.
- NYSE Euronext Earnings News Release with Tables and Operating Data
About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets - the New York Stock Exchange, NYSE Euronext, NYSE MKT, NYSE Alternext and NYSE Arca - represent one-third of the world’s equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index. For more information, please visit: http://www.nyx.com.
Disclaimer and Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext's plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext's results to differ materially from current expectations include, but are not limited to: NYSE Euronext's ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext's 2011 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorité des Marchés Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.